|
1
|
Wan G, Ji L, Xia W, Cheng L and Zhang Y:
Screening genes associated with elevated neutrophiltolymphocyte
ratio in chronic heart failure. Mol Med Rep. 18:1415–1422.
2018.PubMed/NCBI
|
|
2
|
Kannel WB: Incidence and epidemiology of
heart failure. Heart Fail Rev. 5:167–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neubauer S: The failing heart-an engine
out of fuel. N Engl J Med. 356:1140–1151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gulsin GS, Shetye A, Khoo J, Swarbrick DJ,
Levelt E, Lai FY, Squire IB, Arnold JR and McCann GP: Does stress
perfusion imaging improve the diagnostic accuracy of late
gadolinium enhanced cardiac magnetic resonance for establishing the
etiology of heart failure? BMC Cardiovasc Disord. 17:982017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ingwall JS and Weiss RG: Is the failing
heart energy starved? On using chemical energy to support cardiac
function. Circ Res. 95:135–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ashrafian H, Frenneaux MP and Opie LH:
Metabolic mechanisms in heart failure. Circulation. 116:434–448.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murakami A, Nagao K, Juni N, Hara Y and
Umeda M: An N-terminal di-proline motif is essential for fatty
acid-dependent degradation of Δ9-desaturase in Drosophila. J Biol
Chem. 292:19976–19986. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dobrzyn A and Ntambi JM: The role of
stearoyl-CoA desaturase in body weight regulation. Trends
Cardiovasc Med. 14:77–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu G, Lynch JK, Freeman J, Liu B, Xin Z,
Zhao H, Serby MD, Kym PR, Suhar TS, Smith HT, et al: Discovery of
potent, selective, orally bioavailable stearoyl-CoA desaturase 1
inhibitors. J Med Chem. 50:3086–3100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hess D, Chisholm JW and Igal RA:
Inhibition of stearoylCoA desaturase activity blocks cell cycle
progression and induces programmed cell death in lung cancer cells.
PLoS One. 5:e113942010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Theocharisa S, Margeli A and Kouraklis G:
Peroxisome proliferator activated receptor-gamma ligands as potent
antineoplastic agents. Curr Med Chem Anticancer Agents. 3:239–251.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei JJ, Wu X, Peng Y, Shi G, Basturk O,
Yang X, Daniels G, Osman I, Ouyang J, Hernando E, et al: Regulation
of HMGA1 expression by microRNA-296 affects prostate cancer growth
and invasion. Clin Cancer Res. 17:1297–1305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Z, Wan F, Zhuang Q, Zhang Y and Xu
Z: Suppression of miR-127 protects PC-12 cells from LPS-induced
inflammatory injury by downregulation of PDCD4. Biomed
Pharmacother. 96:1154–1162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ciebiera M, Wlodarczyk M, Wrzosek M,
Męczekalski B, Nowicka G, Łukaszuk K, Ciebiera M,
Słabuszewska-Jóźwiak A and Jakiel G: Role of transforming growth
factor β in uterine fibroid biology. Int J Mol Sci. 18:pii: E2435.
2017. View Article : Google Scholar
|
|
15
|
Yoshida K, Murata M, Yamaguchi T and
Matsuzaki K: TGF-β/Smad signaling during hepatic
fibro-carcinogenesis (review). Int J Oncol. 45:1363–1371. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kamato D, Burch ML, Piva TJ, Rezaei HB,
Rostam MA, Xu S, Zheng W, Little PJ and Osman N: Transforming
growth factor-β signalling: Role and consequences of Smad linker
region phosphorylation. Cell Signal. 25:2017–2024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei Q, Liu Q, Ren C, Liu J, Cai W, Zhu M,
Jin H, He M and Yu J: Effects of bradykinin on TGFbeta1induced
epithelialmesenchymal transition in ARPE19 cells. Mol Med Rep.
17:5878–5886. 2018.PubMed/NCBI
|
|
18
|
Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ,
Jing W and Fan YZ: Suppression of lymphangiogenesis in human
lymphatic endothelial cells by simultaneously blocking VEGF-C and
VEGF-D/VEGFR-3 with norcantharidin. Int J Oncol. 41:1762–1772.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lequerica-Fernandez P, Astudillo A and de
Vicente JC: Expression of vascular endothelial growth factor in
salivary gland carcinomas correlates with lymph node metastasis.
Anticancer Res. 27:3661–3666. 2007.PubMed/NCBI
|
|
20
|
Panagiotaki KN, Sideratou Z, Vlahopoulos
SA, Paravatou-Petsotas M, Zachariadis M, Khoury N, Zoumpourlis V
and Tsiourvas D: A Triphenylphosphonium-Functionalized
Mitochondriotropic nanocarrier for efficient Co-Delivery of
doxorubicin and chloroquine and enhanced antineoplastic activity.
Pharmaceuticals (Basel). 10:pii: E91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Guo Z, Wang P and Xu M:
Erythropoietin modulates imbalance of matrix metalloproteinase-2
and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced
cardiotoxicity. Heart Lung Circ. 23:772–777. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adult Acute Myeloid Leukemia Treatment
(PDQ(R)): Patient VersionPDQ Cancer Information Summaries. Bethesda
(MD): 2002
|
|
24
|
Magadum A, Ding Y, He L, Kim T,
Vasudevarao MD, Long Q, Yang K, Wickramasinghe N, Renikunta HV,
Dubois N, et al: Live cell screening platform identifies PPARδ as a
regulator of cardiomyocyte proliferation and cardiac repair. Cell
Res. 27:1002–1019. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu J, Cheng P, Huang GY, Cai GW, Lian FZ,
Wang XY and Gao S: Effects of Xin-Ji-Er-Kang on heart failure
induced by myocardial infarction: Role of inflammation, oxidative
stress and endothelial dysfunction. Phytomedicine. 42:245–257.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Andrés-Manzano MJ, Andrés V and Dorado B:
Oil Red O and hematoxylin and eosin staining for quantification of
atherosclerosis burden in mouse aorta and aortic root. Methods Mol
Biol. 1339:85–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tedesco FS, Dellavalle A, Diaz-Manera J,
Messina G and Cossu G: Repairing skeletal muscle: Regenerative
potential of skeletal muscle stem cells. J Clin Invest. 120:11–19.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Charge SB and Rudnicki MA: Cellular and
molecular regulation of muscle regeneration. Physiol Rev.
84:209–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huan L, Bao C, Chen D, Li Y, Lian J, Ding
J, Huang S, Liang L and He X: MicroRNA-127-5p targets the
biliverdin reductase B/nuclear factor-kB pathway to suppress cell
growth in hepatocellular carcinoma cells. Cancer Sci. 107:258–266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ying H, Kang Y, Zhang H, Zhao D, Xia J, Lu
Z, Wang H, Xu F and Shi L: MiR-127 modulates macrophage
polarization and promotes lung inflammation and injury by
activating the JNK pathway. J Immunol. 194:1239–1251. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
D'Arpino MC, Fuchs AG, Sánchez SS and
Honoré SM: Extracellular matrix remodeling and TGF-β1/Smad
signaling in diabetic colon mucosa. Cell Biol Int. 42:443–456.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gressner AM and Weiskirchen R: Modern
pathogenetic concepts of liver fibrosis suggest stellate cells and
TGF-beta as major players and therapeutic targets. J Cell Mol Med.
10:76–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Hu H and Yin JQ: Therapeutic
strategies against TGF-beta signaling pathway in hepatic fibrosis.
Liver Int. 26:8–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
